אינדקס תגיות  
חפש
הוספת קישור

שי אפרתי

אודות הקישור

Hypertension has been shown to be a risk factor for development of dementia. However, medical treatment of hypertension failed to reduce consistently the risk of dementia. Experimental study pointed to the possibility of difference between different calcium channel blockers (CCB) in their neuro-protective effect. The aim of our study was to evaluate the risk of dementia during treatment of hypertension with different CCBs. This is a retrospective cohort study based on electronic database of a large public health care organization. Study period was 11 years and it included patients aged 40-75 years old, having diagnosis of hypertension without diagnosis of dementia at the starting point, treated with either single specific CCB (study group) or with other than CCBs antihypertensive medications (control group) for at least 30 months during the study period. A total of 15,664 patients that satisfied these criteria were identified: 3,884 were treated with amlodipine, 2,062 were treated with nifedipine, 609 were treated with lercanidipine, and 9,109 never received CCBs. Dementia developed in 765 (4.9%) patients. Adjusted hazard ratio (HR) for dementia in patients treated with amlodipine, nifedipine, and lercanidipine was 0.60 (p < 0.001), 0.89 (NS), and

נתונים

נושא זה הועלה לפני 3 שבועות 4 ימים    |    וכבר נצפה 16 צפיות    |    ו 0 גולשים נכנסו לקישור
מתוך אתר : ncbi.nlm.nih.gov | כניסה לקישור
https://www.ncbi.nlm.nih.gov/pubmed/27392121
תגיות : שי אפרתי  ,  
 

שי אפרתי

 
התוכן והקישורים באתר זה מועלים על ידי הגולשים, הכניסה לקישורים באחריות הגולשים בלבד.